4574.T लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:45):

Stats
आज की मात्रा	99 000.00
औसत मात्रा	488 822
बाजार मूल्य	17.40B
EPS	¥0 ( 2024-02-08 )
अगली कमाई की तारीख	( ¥0 ) 2024-05-09
Last Dividend	¥13.00 ( 2021-12-29 )
Next Dividend	¥0 ( N/A )
P/E	-4.55
ATR14	¥0.925 (0.27%)

मात्रा सहसंबंध

लंबा: -0.05 (neutral)

छोटा: 0.00 (neutral)

Signal:(57.935) Neutral

Taiko Pharmaceutical सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Taiko Pharmaceutical सहसंबंध - मुद्रा/वस्त्र

0.45
( neutral )

0.59
( weak )

0.47
( neutral )

0.55
( weak )

0.08
( neutral )

-0.46
( neutral )

Taiko Pharmaceutical वित्तीय

Annual	2022
राजस्व:	¥5.04B
सकल लाभ:	¥1.08B (21.41 %)
EPS:	¥-112.24

FY	2022
राजस्व:	¥5.04B
सकल लाभ:	¥1.08B (21.41 %)
EPS:	¥-112.24

FY	2021
राजस्व:	¥10.72B
सकल लाभ:	¥2.75B (25.63 %)
EPS:	¥-91.46

FY	2020
राजस्व:	¥17.68B
सकल लाभ:	¥12.42B (70.24 %)
EPS:	¥89.18

Financial Reports:

No articles found.

Taiko Pharmaceutical Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Taiko Pharmaceutical Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0.484 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	¥0.556	2009-03-26
Last Dividend	¥13.00	2021-12-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	18	--
Total Paid Out	¥72.22	--
Avg. Dividend % Per Year	0.00%	--
Score	1.18	--
Div. Sustainability Score	0.484
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2025-02-18)

¥0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.18

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
7613.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
6810.T	Ex Dividend Knight	2023-09-28	Annually	0.00%
6165.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
4902.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
4064.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
3284.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2327.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9274.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
8016.T	Ex Dividend Junior	2024-02-28	Annually	0.00%
7267.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.375	1.500	-7.50	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.144	1.200	-4.80	-5.76	[0 - 0.3]
returnOnEquityTTM	-0.261	1.500	-4.01	-6.02	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.19	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.54	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.719	1.500	1.560	2.34	[0.2 - 2]
debtRatioTTM	0.188	-1.500	6.86	-10.00	[0 - 0.6]
interestCoverageTTM	-85.89	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0.305	-1.500	8.78	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.394	1.000	6.76	6.76	[0.2 - 0.8]
operatingProfitMarginTTM	-0.127	1.000	-4.55	-4.55	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.384	0.800	-0.775	-0.620	[0.5 - 2]
Total Score				0.484

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-6.82	1.000	-0.790	0	[1 - 100]
returnOnEquityTTM	-0.261	2.50	-2.58	-6.02	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.124	1.500	-4.16	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.598

Taiko Pharmaceutical

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`